Ib-tib 140 mg Capsule
$89.52
$69.82
Ib-tib 140 mg Capsule is a targeted therapy designed for adults battling specific hematological malignancies, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), particularly in patients harboring particular genetic mutations. This innovative medication works by inhibiting key pathways that contribute to the growth and survival of cancer cells, effectively slowing disease progression and enhancing patient outcomes. Additionally, Ib-tib is utilized in the management of Waldenström's macroglobulinemia (WM), a rare form of non-Hodgkin lymphoma characterized by elevated immunoglobulin M (IgM) levels. Patients considering Ib-tib should be aware of potential side effects, including an increased risk of infections and other hematological complications, necessitating close monitoring by healthcare professionals. It is crucial to disclose any existing health conditions or medications to your physician to ensure safe usage. With its precise mechanism of action, Ib-tib 140 mg Capsule represents a significant advancement in the treatment landscape for these challenging cancers, offering hope to many. Always consult your healthcare provider for tailored advice and comprehensive treatment plans.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Ib tib 140 mg capsule is primarily used in adults with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). This medication targets the underlying mechanisms of these blood cancers, helping to manage symptoms and disease progression. Patients can expect improved outcomes when treated with Ib tib 140 mg capsule as part of their therapeutic regimen. It is often utilized in cases where other treatments have been ineffective.
• In patients with CLL or SLL who have a 17p deletion, Ib tib 140 mg capsule plays a crucial role in treatment. This specific genetic alteration can complicate the disease's management, making effective therapies essential. The use of Ib tib 140 mg capsule can provide significant benefits in controlling the disease in these patients. It is a vital option in the therapeutic landscape for those facing this particular challenge.
• Ib tib 140 mg capsule is also indicated for adults with Waldenström's macroglobulinemia (WM). This rare type of blood cancer can lead to various complications, and effective treatment is necessary to alleviate symptoms. By incorporating Ib tib 140 mg capsule into the treatment plan, healthcare providers aim to stabilize the disease and improve the quality of life for affected individuals. It serves as an important tool in the management of WM.
• Additionally, Ib tib 140 mg capsule is used in both adults and children aged one year and older who are experiencing chronic graft versus host disease (cGVHD) after failing one or more lines of systemic therapy. This condition can arise following stem cell transplants, and effective management is crucial. The administration of Ib tib 140 mg capsule can help mitigate the effects of cGVHD, providing relief and enhancing the overall treatment experience. Its use in this context demonstrates its versatility and effectiveness in complex therapeutic scenarios.
Benefits
Effective Treatment for CLL and SLL: Ib-tib 140 mg Capsule is proven to be effective in treating chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL), providing patients with an essential treatment option for these conditions.
Targets Specific Genetic Mutations: The Ib-tib Cancer Medicine is particularly beneficial for adults with CLL/SLL who have specific genetic mutations, offering a tailored approach to treatment.
Management of Waldenström's Macroglobulinemia: Ib-tib Oral Capsule is effective in treating Waldenström's macroglobulinemia (WM), a rare type of non-Hodgkin lymphoma, improving outcomes for patients with this condition.
Chronic Graft-Versus-Host Disease (cGVHD): Ib-tib 140 mg is also approved for treating cGVHD in adults and children aged 1 year and older when other treatments have failed, providing an option for patients facing complications after stem cell transplants.
By effectively managing symptoms and slowing disease progression, Ib-tib Cancer Medicine can enhance the quality of life for patients living with CLL, SLL, WM, and cGVHD.
Side Effects
Ibrutinib Anti-Cancer Drug can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Tiredness
• Low red blood cell count (anaemia)
• Bruising
• Diarrhea
• Muscle, bone, and joint pain
• Fever
Common Side Effects
• Muscle spasms
• Mouth sores (stomatitis)
• Bleeding
• Nausea
• Stomach pain
• Pneumonia
• Headache
How To Use
To take or give Ib-tib 140 mg Capsule, follow your doctor's instructions carefully. This Ib-tib 140 mg Capsule is usually taken once a day with a full glass of water, either with or without food. Swallow the capsules whole; do not crush, chew, or break them. Keep to a schedule and try to take your doses at the same time each day. If you miss a dose, take it as soon as possible on the same day. Do not take extra doses to make up for a missed dose. Avoid grapefruit or grapefruit juice while you are taking Ib-tib Oral Capsule, as it may interfere with the action of the medicine. Keep the medicine in a safe place away from children, and do not give it to anyone else, even if they have similar symptoms. If you have any questions or experience side effects, contact your doctor for advice.
Safety Advice
• Alcohol: It is not known whether it is safe to drink alcohol with Ib-tib 140 mg. Please consult your doctor.
• Kidney: Ib-tib 140 mg Capsule should be used with caution in patients with kidney disease. The dose of Ib-tib Oral Capsule may need to be adjusted. Please consult your doctor.
• Breastfeeding: Ib-tib Cancer Medicine should be used with caution during breast-feeding. Breastfeeding should be continued until the mother's treatment is complete and the drug has been eliminated from her body.
• Liver: Ibrutinib Anti-Cancer Drug should be used with caution in patients with liver disease. The dose of Ib-tib 140 mg may need to be adjusted. Please consult your doctor.
• Pregnancy: Ib-tib 140 mg Capsule is not safe to use during pregnancy, as there is clear evidence of a risk to the developing baby. However, the doctor may rarely prescribe it in certain life-threatening situations where the benefits outweigh the potential risks. Please consult your doctor.
• Driving: Ib-tib Oral Capsule can cause side effects that may affect your ability to drive a car.